Helen J. Mayfield , Benn Sartorius , Ramona Muttucumaru , Sarah Sheridan , Maddison Howlett , Beatris Mario Martin , Shannon M. Hedtke , Emma Field , Robert Thomsen , Satupaitea Viali , Patricia M. Graves , Colleen L. Lau
{"title":"萨摩亚2019-2023年抗原阳性个体中淋巴丝虫病抗原血症和微丝虫病在4.5年内的进展情况","authors":"Helen J. Mayfield , Benn Sartorius , Ramona Muttucumaru , Sarah Sheridan , Maddison Howlett , Beatris Mario Martin , Shannon M. Hedtke , Emma Field , Robert Thomsen , Satupaitea Viali , Patricia M. Graves , Colleen L. Lau","doi":"10.1016/j.ijid.2025.107891","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>The first round of triple-drug mass drug administration (MDA) for lymphatic filariasis (LF) in Samoa was in 2018. This study aims to i) examine progression of LF antigen (Ag) and microfilaria (Mf) in Ag-positive individuals from 2019-2023; and ii) compare Ag/Mf prevalence in household members of Mf-positive vs Mf-negative participants.</div></div><div><h3>Methods</h3><div>In 2023, we tested Ag-positive participants (indexes) from a 2019 survey in Samoa, and their household members. We tested for Ag (Alere/Abbott Filariasis Test Strip) and Mf. We examined changes in Ag/Mf status in index participants and compared Ag/Mf prevalence between household members of Mf-positive and Mf-negative indexes.</div></div><div><h3>Results</h3><div>We recruited 91 indexes and 317 household members. In 2023, all 17 Mf-positive indexes remained Ag-positive and 11/15 with Mf results (73.3%) were Mf-positive. Of 74 Mf-negative indexes, 79.7% remained Ag-positive in 2023 and 31.1% became Mf-positive. Household members of Mf-positive indexes were more likely to be Ag-positive (odds ratios 3.3, 95% CI 1.0-10.3) compared to those of Mf-negative indexes.</div></div><div><h3>Conclusion</h3><div>Our results raise concerns regarding long-term effectiveness of a single-dose of triple-drug MDA for sustained clearance of Mf in Samoa. Guidelines for follow-up and treatment of Ag/Mf-positive people and household members are urgently required.</div></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":"155 ","pages":"Article 107891"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Progression of lymphatic filariasis antigenaemia and microfilaraemia over 4.5 years in antigen-positive individuals, Samoa 2019-2023\",\"authors\":\"Helen J. Mayfield , Benn Sartorius , Ramona Muttucumaru , Sarah Sheridan , Maddison Howlett , Beatris Mario Martin , Shannon M. Hedtke , Emma Field , Robert Thomsen , Satupaitea Viali , Patricia M. Graves , Colleen L. Lau\",\"doi\":\"10.1016/j.ijid.2025.107891\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>The first round of triple-drug mass drug administration (MDA) for lymphatic filariasis (LF) in Samoa was in 2018. This study aims to i) examine progression of LF antigen (Ag) and microfilaria (Mf) in Ag-positive individuals from 2019-2023; and ii) compare Ag/Mf prevalence in household members of Mf-positive vs Mf-negative participants.</div></div><div><h3>Methods</h3><div>In 2023, we tested Ag-positive participants (indexes) from a 2019 survey in Samoa, and their household members. We tested for Ag (Alere/Abbott Filariasis Test Strip) and Mf. We examined changes in Ag/Mf status in index participants and compared Ag/Mf prevalence between household members of Mf-positive and Mf-negative indexes.</div></div><div><h3>Results</h3><div>We recruited 91 indexes and 317 household members. In 2023, all 17 Mf-positive indexes remained Ag-positive and 11/15 with Mf results (73.3%) were Mf-positive. Of 74 Mf-negative indexes, 79.7% remained Ag-positive in 2023 and 31.1% became Mf-positive. Household members of Mf-positive indexes were more likely to be Ag-positive (odds ratios 3.3, 95% CI 1.0-10.3) compared to those of Mf-negative indexes.</div></div><div><h3>Conclusion</h3><div>Our results raise concerns regarding long-term effectiveness of a single-dose of triple-drug MDA for sustained clearance of Mf in Samoa. Guidelines for follow-up and treatment of Ag/Mf-positive people and household members are urgently required.</div></div>\",\"PeriodicalId\":14006,\"journal\":{\"name\":\"International Journal of Infectious Diseases\",\"volume\":\"155 \",\"pages\":\"Article 107891\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-03-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1201971225001146\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971225001146","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
目的:萨摩亚淋巴丝虫病(LF)的第一轮三联药大规模给药(MDA)是在2018年。本研究旨在i)检测2019- 2023年Ag阳性个体LF抗原(Ag)和微丝蚴(Mf)的进展;ii)比较Mf阳性和Mf阴性参与者家庭成员的Ag/Mf患病率。方法:2023年,我们对萨摩亚2019年调查中的ag阳性参与者(指数)及其家庭成员进行了测试。我们检测了Ag (Alere/Abbott丝虫病试纸)和Mf。我们检查了指数参与者的Ag/Mf状况的变化,并比较了Mf阳性和Mf阴性指数家庭成员之间的Ag/Mf患病率。结果:共纳入91项指标和317户家庭成员。2023年,17项Mf阳性指标均为ag阳性,11/15例Mf阳性(73.3%)。74项mf阴性指标中,2023年79.7%为ag阳性,31.1%为mf阳性。与mf阴性指数的家庭成员相比,mf阳性指数的家庭成员更容易出现ag阳性(OR 3.3, 95% CI 1.0-10.3)。结论:我们的研究结果引起了人们对萨摩亚单剂量三药丙二醛持续清除Mf的长期有效性的关注。迫切需要对银/中性粒细胞阳性者和家庭成员进行随访和治疗的指南。
Progression of lymphatic filariasis antigenaemia and microfilaraemia over 4.5 years in antigen-positive individuals, Samoa 2019-2023
Objectives
The first round of triple-drug mass drug administration (MDA) for lymphatic filariasis (LF) in Samoa was in 2018. This study aims to i) examine progression of LF antigen (Ag) and microfilaria (Mf) in Ag-positive individuals from 2019-2023; and ii) compare Ag/Mf prevalence in household members of Mf-positive vs Mf-negative participants.
Methods
In 2023, we tested Ag-positive participants (indexes) from a 2019 survey in Samoa, and their household members. We tested for Ag (Alere/Abbott Filariasis Test Strip) and Mf. We examined changes in Ag/Mf status in index participants and compared Ag/Mf prevalence between household members of Mf-positive and Mf-negative indexes.
Results
We recruited 91 indexes and 317 household members. In 2023, all 17 Mf-positive indexes remained Ag-positive and 11/15 with Mf results (73.3%) were Mf-positive. Of 74 Mf-negative indexes, 79.7% remained Ag-positive in 2023 and 31.1% became Mf-positive. Household members of Mf-positive indexes were more likely to be Ag-positive (odds ratios 3.3, 95% CI 1.0-10.3) compared to those of Mf-negative indexes.
Conclusion
Our results raise concerns regarding long-term effectiveness of a single-dose of triple-drug MDA for sustained clearance of Mf in Samoa. Guidelines for follow-up and treatment of Ag/Mf-positive people and household members are urgently required.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.